Arena Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.11.15	EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q3 Earnings Report (RTTNews)
29.10.15	Arena Pharma Announces Initiation Of Patient Dosing In Phase 1b Trial Of APD371 (RTTNews)
28.10.15	Viral Therapy For Cancer Gets FDA Nod, ARNA Slimming Down, ZLTQ Well-Sculpted (RTTNews)
27.10.15	Arena Pharma To Reduce Its US Workforce - Quick Facts (RTTNews)
05.10.15	Arena Pharmaceuticals CEO Jack Lief To Retire (RTTNews)
05.08.15	EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q2 Earnings Report (RTTNews)
05.08.15	Arena Pharma Swings To Q2 Loss (RTTNews)
16.06.15	Arena CFO Robert Hoffman Resigns (RTTNews)
11.05.15	Arena Pharma Q1 Results Top Estimates (RTTNews)
29.04.15	Arena Reports Favorable Results On Phase 1 Single-Ascending Dose Trial Of APD371 (RTTNews)
03.03.15	Arena Pharma Q4 Loss Widens, Misses View (RTTNews)
02.03.15	Arena Pharmaceuticals Q4 Loss Widens (RTTNews)
03.02.15	Arena Says Ildong Pharma Gets Marketing Approval For Belviq In Korea (RTTNews)
21.01.15	Arena Pharma Sells 21 Mln Shares (RTTNews)
07.01.15	Arena Pharma: APD334 Shows Dose-dependent Lymphocyte Lowering In Phase 1b Trial (RTTNews)
03.11.14	Arena Says Phase 2 Trial For Lorcaserin Meets Primary Efficacy Endpoint (RTTNews)
29.10.14	Belviq & Phentermine: A Diet Drug Cocktail In The Making? (RTTNews)
02.09.14	FDA Grants Orphan Drug Status To Arena's PAH Drug APD811 (RTTNews)
13.05.14	Arena Pharma Q1 Loss Widens, Misses View (RTTNews)
12.05.14	Arena Pharma Q1 Loss Widens - Quick Facts (RTTNews)
27.02.14	Arena Pharmaceuticals Q4 Loss Widens - Quick Facts (RTTNews)
12.02.14	New Weight-loss Drugs Look Like Slim Pickings, Say Dartmouth Researchers (RTTNews)
08.11.13	Arena Expands Deal With Eisai On Obesity Drug Sales; Q3 Loss Widens (RTTNews)
21.10.13	Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros (PR Newswire)
15.10.13	Arena Pharmaceuticals Reports That Eisai Will Double BELVIQ® (lorcaserin HCl) CIV Sales Force by December (PR Newswire)
08.10.13	Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp. (PR Newswire)
25.09.13	Drug Approvals, Data Presentations, Conferences, Increased Funding, and Merger Agreements - Research Report on Theravance, Arena, Exelixis, Verenium, and Enanta (PR Newswire)
23.09.13	Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference (PR Newswire)
18.09.13	Arena Pharmaceuticals to Present Clinical Data for BELVIQ® (lorcaserin HCl) CIV at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) (PR Newswire)
06.09.13	Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference (PR Newswire)
03.09.13	Successful Clinical Trials, Data Presentations, Promising Studies, Fulfilled Agreements and Investors Conferences - Research Report on Arena, BioMarin, Clovis Oncology, MannKind, and Medivation (PR Newswire)
28.08.13	Arena Pharma Closes Phase 1b Trial Evaluating APD811 For PAH - Quick Facts (RTTNews)
28.08.13	Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension (PR Newswire)
14.08.13	Arena Pharmaceuticals GmbH in Zofingen setzt globale Expansion in potenzielle Märkte für neues Abnehmmittel BELVIQ® (Lorcaserin HCl) fort (PR Newswire)
14.08.13	La société Arena Pharmaceuticals GmbH de Zofingen poursuit l'élargissement international du marché potentiel du nouveau médicament amaigrissant BELVIQ® (hydrochlorure de lorcaserine) (PR Newswire)
09.08.13	Pharmaceutical Companies Announce Quarterly Financial Results - Research Report on Jazz, Acadia, Arena, Santarus, and Incyte (PR Newswire)
02.08.13	Regulatory Approvals, New Collaborations, Awards, and Strong Revenue Growth - Research Report on Stereotaxis, Arena, USANA, NuVasive, and MAKO (PR Newswire)
01.08.13	Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results (PR Newswire)
29.07.13	Arena Pharma, Geron, Incyte, and Spectrum Pharma Under AAAResearchReports.com Microscope (PR Newswire)
29.07.13	Arena Pharma, Geron, Incyte, and Spectrum Pharma Under AAAResearchReports.com Microscope (PR Newswire)
25.07.13	Arena Pharmaceuticals and CY Biotech Enter into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in Taiwan (PR Newswire)
24.07.13	Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, August 1 (PR Newswire)
11.05.12	Wall Street-Schluss: Dow Jones endet im Minus, JPMorgan im Fokus (Aktiencheck)
11.05.12	Wall Street Update: Leichte Zugewinne, JPMorgan im Fokus (Aktiencheck)
11.05.12	Wall Street Eröffnung: Leichter, Fehlspekulation von JPMorgan belastet, Arena Pharma mit heftigem Kurssprung (Aktiencheck)
08.04.06	Biotech - Neue Namen mit Gewicht (EurAmS) (n/a)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

27.11.24		Minuszeichen in New York: Dow Jones beendet die Sitzung im Minus
27.11.24		Dow Jones aktuell: Dow Jones legt nachmittags den Rückwärtsgang ein
27.11.24		Schwacher Wochentag in New York: Dow Jones verliert am Mittwochmittag
27.11.24		Dow Jones 30 Industrial-Titel Johnson Johnson-Aktie: So viel Verlust hätte eine Johnson Johnson-Investition von vor 3 Jahren eingebracht
26.11.24		Zuversicht in New York: Zum Handelsende Gewinne im NASDAQ 100
26.11.24		Dow Jones aktuell: Dow Jones zum Handelsende in Grün

27.11.24

Minuszeichen in New York: Dow Jones beendet die Sitzung im Minus

27.11.24

Dow Jones aktuell: Dow Jones legt nachmittags den Rückwärtsgang ein

27.11.24

Schwacher Wochentag in New York: Dow Jones verliert am Mittwochmittag

27.11.24

Dow Jones 30 Industrial-Titel Johnson Johnson-Aktie: So viel Verlust hätte eine Johnson Johnson-Investition von vor 3 Jahren eingebracht

26.11.24

Zuversicht in New York: Zum Handelsende Gewinne im NASDAQ 100

26.11.24

Dow Jones aktuell: Dow Jones zum Handelsende in Grün